AcuCort AB
STO: ACUC.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Jonas Jonmark
- Employees
- 4
- Headquarters
- Lund, Sweden
- IPO year
- 2017
- Market cap
- SEK 162.7M
- Website
- https://www.acucort.com
Loading ACUC…
Loading profile data…Frequently asked questions about ACUC
What does AcuCort AB (ACUC.ST) do?
AcuCort AB (publ) develops and commercializes glucocorticoid dexamethasone films for the treatment of acute allergic conditions. It offers Zeqmelit, a medicine used for the treatment of severe and acute allergic reactions, croup in children, and chemotherapy-induced nausea and vomiting, as well as for the treatment of COVID-19 patients who need...
Where does ACUC.ST trade?
AcuCort AB (ACUC.ST) trades on the Stockholm Stock Exchange.
What sector is ACUC.ST in?
AcuCort AB (ACUC.ST) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of AcuCort AB?
Jonas Jonmark is the chief executive officer of AcuCort AB (ACUC.ST).
Where is AcuCort AB headquartered?
AcuCort AB is headquartered in Sweden.
Does ACUC.ST pay a dividend?
AcuCort AB (ACUC.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ACUC.ST go public?
AcuCort AB (ACUC.ST) completed its initial public offering in 2017.